Cours ESSA Pharma Inc. Toronto S.E.
Actions
EPI
CA29668H7085
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 371 M 271 M 247 M |
---|---|---|---|---|---|
Résultat net 2024 * | -48 M -35,12 M -31,99 M | Résultat net 2025 * | -78 M -57,06 M -51,99 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 0 | Trésorerie nette 2025 * | - 0 0 | VE / CA 2025 * | - |
PER 2024 * |
-7,72
x | PER 2025 * |
-5,49
x | Employés | 50 |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 97,72% |
Dernier transcript sur ESSA Pharma Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 24/06/15 |
David Wood
DFI | Director of Finance/CFO | 66 | 01/10/13 |
Peter Virsik
COO | Chief Operating Officer | - | 01/08/16 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 05/03/15 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 31/07/19 |
Richard Glickman
CHM | Chairman | 65 | 01/10/10 |
Varia. 1 janv. | Capi. | |
---|---|---|
+1,77% | 42,75 Md | |
+47,70% | 41,61 Md | |
+12,24% | 41,34 Md | |
-8,83% | 26,59 Md | |
+7,44% | 25,49 Md | |
-23,01% | 18,12 Md | |
+30,56% | 12,24 Md | |
-1,82% | 11,76 Md | |
+8,35% | 11 Md |